Acorda Therapeutics

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.

We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders.

We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. We achieve our goals by:

• investing in research and development

• collaborating closely with the patient, medical and scientific communities

• retaining employees with compassion and commitment

Acorda has been voted one of the best companies to work for in New York for the past five years in a row, as a result of our dynamic environment, strong corporate culture, significant emphasis on research and development, and a robust product pipeline. We are positioned to be an industry leader, poised for exceptional growth.

Type
Public
HQ
Ardsley, US
Founded
1995
Employees
535 (est)
Acorda Therapeutics was founded in 1995 and is headquartered in Ardsley, US

Acorda Therapeutics Locations

Ardsley, US
Chelsea, US

Acorda Therapeutics Metrics

Acorda Therapeutics Summary

Market capitalization

$936 M

Closing share price

$20.3
Acorda Therapeutics's latest market capitalization is $936 M.

Acorda Therapeutics Market Value History

Acorda Therapeutics Online Presence

Acorda Therapeutics News

Acorda Therapeutics Company Life

You may also be interested in